MedTrace Logo

A Study in Older Participants Who Have Fallen and Have Muscle Weakness

NCT01604408 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2018-04-25

Study results available
· View outcomes & findings →

Summary

LY2495655 is an investigational drug being tested for muscle wasting.

Conditions

  • Muscle Weakness

Interventions

BIOLOGICAL

LY2495655

Administered SC

DRUG

Placebo

Administered SC

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • United States
  • Argentina
  • Australia
  • France
  • Germany
  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01604408 on ClinicalTrials.gov